For example, survival analyses suggest that RBM24 may be a potential prognostic biomarker for head and neck squamous cell carcinoma (HNSCC) and skin cutaneous melanoma (SKCM) patients [58,59]. Here, RBM24 is linked to head and neck squamous cell carcinoma.